Skip to content

Clinical trials

Phase 1 Multiple Sclerosis trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 1 Country / region: United States Clear all

105 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20041
20051
20062
20074
20083
20095
20106
20113
20126
20132
20144
20154
20164
20185
20196
20204
20219
20223
20237
202410
20256
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed57
Recruiting15
Terminated12
Active, not recruiting9
Unknown status5
Suspended3
Not yet recruiting3
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen9
National Institute of Neurological Disorders and Stroke (NINDS)6
Oregon Health and Science University4
Hoffmann-La Roche3
Institute for Neurodegenerative Disorders3
Kessler Foundation3
Griffin Hospital2
Sanofi2
University of Alabama at Birmingham2
University of Illinois at Urbana-Champaign2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis105
Multiple Sclerosis, Relapsing-Remitting17
Multiple Sclerosis, Chronic Progressive15
Autoimmune Diseases8
Demyelinating Diseases5
Alzheimer Disease4
Myasthenia Gravis3
Parkinson Disease3
Spinal Cord Injuries3
Arthritis, Rheumatoid2

Trials

Showing 1 to 25 of 105. Each trial links to its page on Pharma Observatory.

5 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.